MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000516074

Медицинская библиотека · Dementia and geriatric cognitive disorders extra · 2021

The Neuroinflammasome in Alzheimer's Disease and Cerebral Stroke.

Lee Jong-Hoon, Lee Chul Joong, Park Jungwuk, Lee So Jeong, Choi Su-Hee

СтатьяПеревод в очереди

Аннотация

AIM/

BACKGROUND

This review investigated a patient with Alzheimer's disease (AD) treated with 4,4'-diaminodiphenyl sulfone (DDS) as a neuroinflammasome competitor.

METHODS

We monitored AD's progression through numeric clinical staging (NCS) with a new biomarker. NCS was determined by the presence of AD symptoms and neuropsychiatric (NP) symptoms caused by anti-AD (AAD) drugs (D) as a biomarker. We also monitored the function of DDS for stroke in a no-intake emergency state.

RESULTS

By introducing (D), AD's progression was monitored through NCS staging. AAD side effects and neuropsychiatric symptoms were identified. DDS was stopped in patients with stroke with NCS 6 caused by AAD, and it rapidly proceeded to cerebral infarct.

CONCLUSIONS

AAD can occasionally exacerbate AD and stroke. DDS can alleviate mild cognitive impairment (MCI), early AD and stroke. We clinically confirmed the role of DDS as a neuroinflammasome competitor after stroke. DDS preserved neuronal survival within 24-55 h in the Seoul Study cohort.

Для цитирования: Lee Jong-Hoon, Lee Chul Joong, Park Jungwuk, Lee So Jeong, Choi Su-Hee. The Neuroinflammasome in Alzheimer's Disease and Cerebral Stroke.. Dementia and geriatric cognitive disorders extra. 2021. DOI: 10.1159/000516074.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.